Jamrex Remedies Private Limited
About Jamrex Remedies Private Limited
Data last updated:
Jamrex Remedies Private Limited is a private limited company based in Saravananpatti, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U51909TZ2016PTC028081.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mohammad Anzar and Priya Singh.
Its last annual general meeting (AGM) was held on 30 October 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Saravananpatti, Tamil Nadu.
As per the financials filed for FY 2020, the company reported a revenue of ₹25,530, a decline of 98% compared to the previous year. For the same year it recorded a net loss of ₹19,512 (net margin -76.4%) and EBITDA of -₹19,512 (EBITDA margin -76.4%).
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Jamrex Remedies Private Limited's registered office is in Saravananpatti, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressCd – 804 Metropolis Apt Kgisl SEZ – Chil Main R, Oad, Saravananpatti, Tamil Nadu, India – 641035
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Jamrex Remedies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Jamrex Remedies is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
Financials of Jamrex Remedies Private Limited
FY 2020 filings availableJamrex Remedies Private Limited reported revenue of ₹25,530 (down 98% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 98% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹25,530 | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹19,512 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹19,512 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -76.4% | |||
| Net Profit Margin | -76.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Jamrex Remedies Private Limited, buy the company report.
Board of directors of Jamrex Remedies Private Limited
Jamrex Remedies has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Anzar | Director | 10 Oct 2016 | 10 Years 0 Months | Current |
| Priya Singh | Director | 10 Oct 2016 | 10 Years 0 Months | Current |
| Mohammad Hassan Moidul | Director | 10 Oct 2016 | 10 Years 0 Months | Current |
| Horairajilani Khan | Director | 10 Oct 2016 | 10 Years 0 Months | Current |
Auditor
Jamrex Remedies Private Limited is audited by RAJIV PRIYANKA & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJIV PRIYANKA & ASSOCIATES | FY 2020 | 006513C |
Shareholding
The shareholding of Jamrex Remedies Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Jamrex Remedies Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Jamrex Remedies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jamrex Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Jamrex Remedies Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Jamrex Remedies Private Limited has 4 board changes on record since 2016: 4 appointments. The latest: Horairajilani Khan was appointed as Director on 10 Oct 2016.
Frequently asked questions
Jamrex Remedies is an active private limited company based in Saravananpatti, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 October 2016 (10+ years old) and is registered under CIN U51909TZ2016PTC028081.
Jamrex Remedies has 4 current directors:
- Mohammad Anzar - Director
- Priya Singh - Director
- Mohammad Hassan Moidul - Director
- Horairajilani Khan - Director
The latest financial statements of Jamrex Remedies on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 30 October 2020. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Jamrex Remedies is U51909TZ2016PTC028081. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jamrex Remedies was incorporated on 10 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Coimbatore.
Horairajilani Khan was appointed as Director on 10 Oct 2016. Mohammad Anzar was appointed as Director on 10 Oct 2016. Mohammad Hassan Moidul was appointed as Director on 10 Oct 2016. Jamrex Remedies has 4 board changes on record in total.
The registered office of Jamrex Remedies is at Cd – 804 Metropolis Apt Kgisl SEZ – Chil Main R, Oad, Saravananpatti, Tamil Nadu, India – 641035.
Jamrex Remedies operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Jamrex Remedies is active non-compliant as of 05 September 2026. The company is actively filing with the Registrar of Companies.
Jamrex Remedies can be reached at its registered office: Cd – 804 Metropolis Apt Kgisl SEZ – Chil Main R, Oad, Saravananpatti, Tamil Nadu, India – 641035.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
